| Trial ID: | L5861 |
| Source ID: | NCT00790660
|
| Associated Drug: |
Asp1941
|
| Title: |
A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: ASP1941|DRUG: Placebo
|
| Outcome Measures: |
Primary: Evaluation of safety through clinical safety labs and adverse events, 6 Weeks | Secondary: Evaluation of routine PK and PD parameters, 6 Weeks
|
| Sponsor/Collaborators: |
Sponsor: Astellas Pharma Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
61
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-10-23
|
| Completion Date: |
2009-03-06
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-14
|
| Locations: |
San Antonio, Texas, 78229, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00790660
|
